PEO
Large Employers Tighten GLP-1 Coverage as Healthcare Costs Rise
By Anthony Beck, . Insurance Wire.
Large employers are placing greater emphasis on controlling prescription drug spending as healthcare costs continue to rise.
According to Brown & Brown's 2027 Employer Health and Benefits Strategy Survey, 45% of surveyed employers provide coverage for GLP-1 medications used for weight loss. Among those offering coverage, 77% report restrictions beyond standard prior authorization.
The survey included 998 employers with at least 200 U.S.-based employees, making its findings more representative of larger organizations than small businesses.
Brown & Brown also projects average annual healthcare cost increases of approximately 10% for 2026 and 2027.
---
How Employers Are Restricting GLP-1 Coverage
GLP-1 medications include treatments prescribed for obesity and type 2 diabetes, although individual drugs have different FDA-approved uses.
Among surveyed employers covering these medications for weight loss, 45% require additional clinical criteria beyond FDA prescribing guidelines, 43% limit coverage to specific formulary medications, and 33% require participation in a lifestyle or weight-management program.
These requirements can affect whether an employee receives insurance coverage for a prescribed medication, even when the prescription meets FDA-approved indications.
Coverage restrictions for weight management should not be confused with those applying to GLP-1 medications prescribed for diabetes or other approved conditions.
---
Why Self-Funded Employers Have Greater Control
Under a self-funded health plan, the employer generally pays covered medical and pharmacy claims and has greater authority to determine plan benefits, subject to applicable law.
The employer may work with a pharmacy benefit manager (PBM) or third-party administrator to establish formularies, authorization requirements and other prescription coverage rules.
Fully insured arrangements operate differently. The insurance carrier assumes the claims risk and generally establishes the coverage provisions available through its insurance products.
Employers purchasing fully insured coverage typically select from available plan options rather than independently determining authorization requirements for individual medications.
Brown & Brown's survey included employers with at least 200 employees but was not limited to self-funded plans. Its findings therefore reflect reported coverage practices rather than restrictions independently established by every participating employer.
---
What This Means for Businesses Using a PEO
Professional Employer Organizations (PEOs) may offer access to group health insurance programs in which prescription drug coverage is established through the PEO's benefits program and its carrier or administrator.
Individual clients participating in a PEO-sponsored master health plan generally cannot independently modify GLP-1 coverage requirements.
For businesses comparing PEO health insurance options, important considerations include whether weight-loss medications are covered, which clinical requirements apply and how prescription benefits compare with existing coverage.
High GLP-1 utilization can also contribute to higher PEO health insurance renewals. Renewal pricing commonly considers both the overall insurance pool's claims experience and the individual client's medical loss ratio (MLR). Significant GLP-1 claims can increase renewal costs, depending on how heavily the client's claims experience is weighted.
---
Balancing Cost Control and Employee Benefits
GLP-1 medications can represent substantial recurring pharmacy expenses, particularly when prescribed for long-term weight management.
For self-funded employers, increased utilization directly affects claims spending. Fully insured employers may experience the financial impact through premium pricing and future renewals.
Brown & Brown's findings indicate that larger employers are increasingly using coverage restrictions to manage these expenses rather than eliminating weight-loss drug coverage entirely.
Benefits teams reviewing plan options should consider prescription coverage, clinical eligibility requirements and authorization procedures alongside premiums and other plan costs.
For employees already receiving treatment, changes to coverage can also affect access to medications, making renewal communications and effective dates important.
---
Sources
Brown & Brown — 2027 Employer Health and Benefits Strategy Survey, November 9, 2026 https://www.globenewswire.com/news-release/2026/11/09/3398195/0/en/the-healthcare-cost-crisis-is-reshaping-employer-benefits-strategies-brown-brown-survey-reveals.html
Insurance Business — Cost Crisis Pushes Employers to Defer to Advisors as Benefits Pressure Mounts https://www.insurancebusinessmag.com/us/news/benefits/cost-crisis-pushes-employers-to-defer-to-advisors-as-benefits-pressure-mount-596649.aspx
KFF — 2025 Employer Health Benefits Survey https://www.kff.org/health-costs/2025-employer-health-benefits-survey/
Insurance Wire provides news and information, not insurance, legal, or financial advice. Consult a qualified professional about your specific needs.